It's just an opinion, as I said. Here's the thing... look...

It's just an opinion, as I said.

Here's the thing... look through all the CE processes, studies and approvals; they're all dx - diagnosis.

Who am I to remind substantial holders and prolific posters that FDA is a whole other level of approval? Despite what's been repeated, FDA approvals for virtual treatments now include scope to use continuous learning without re-approval; the capacity to evolve and learn is built in to the approval.

This necessarily means that the architecture to support such functionality is robust.